Changeflow GovPing Pharma & Drug Safety Priestia Megaterium Patent Publication EP202603...
Routine Notice Added Final

Priestia Megaterium Patent Publication EP2026030226A1

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has published patent application EP2026030226A1 concerning Priestia Megaterium. The publication date is March 18, 2026. Inventor designation has not yet been filed.

What changed

This document is a patent publication from the European Patent Office (EPO) for the microorganism Priestia Megaterium, identified by publication number EP2026030226A1, with a publication date of March 18, 2026. The International Patent Classification (IPC) codes indicate relevance to biotechnology and agricultural applications.

As this is a patent publication, there are no immediate compliance obligations for regulated entities. However, companies in the pharmaceutical and biotechnology sectors should note this publication for potential intellectual property considerations and competitive landscape monitoring. The designation of the inventor has not yet been filed, which may be a point of future clarification.

Source document (simplified)

← EPO Patent Bulletin

PRIESTIA MEGATERIUM

Publication EP2026030226A1 Kind: A1 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

C12N 1/20 20260101AFI20260207BHEP A01N 63/22 20200101ALI20260207BHEP A01P 21/00 20060101ALI20260207BHEP A01P 7/04 20060101ALI20260207BHEP C12R 1/11 20060101ALI20260207BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP2026030226A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Biotechnology Research Patent Filing
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Biotechnology Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.